To test the FN/αvβ3 integrin binding as a novel target for the treatment of thyroid cancer, we tested DisBa-01, a recombinant His-tag fusion, RGD-disintegrin from Bothrops alternatus snake venom. The gene discussed is FN1; the disease is thyroid cancer.